MSB 7.69% $1.19 mesoblast limited

Endpoints take,FDA reluctant to approve one single arm...

  1. 25,349 Posts.
    lightbulb Created with Sketch. 1377
    Endpoints take,
    FDA reluctant to approve one single arm trial..
    Parents reluctant to enrol kids in trials that will
    see them receive a placibo....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.